VRXA Veraxa Biotech AG - Post de-SPAC
Nasdaq · SEC CIK 2079109 · EDGAR
- Bought, last 12 months
- $82.7K 2 purchases by 2 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 2 since 2026-08-31, latest 2026-08-31 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Baumann Oliver Rolf | Dir | $75.0K | — |
| Antz Christoph Rudiger | CEO, Dir | $7,650 | — |
Transactions 2
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-08-31 16:10 | 2026-08-27 | VRXA | Baumann Oliver Rolf | Dir | P - Purchase | $1.50 | +50.0K | 5.77M | +0.9% | +$75.0K |
| 2026-08-31 16:10 | 2026-08-27 | VRXA | Antz Christoph Rudiger | CEO, Dir | P - Purchase | $1.53 | +5,000 | 5,000 | New | +$7,650 |
Purchase Sale Sale after option exercise All abbreviations